To examine the ferroptosis‐ and RB1CC1‐dependent transcriptional program in tumour cells, ChIP‐Seq was performed using anti‐RB1CC1 and anti‐H4K12Ac antibodies in HepG2 cells. The gene discussed is RB1CC1; the disease is neoplasm.